(Q44016944)

29 November 2017

Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental (English)

1 reference

29 November 2017

Rania Nasrallah

1

1 reference

29 November 2017

Susan J Robertson

series ordinal

2

1 reference

29 November 2017

Jacob Karsh

series ordinal

3

1 reference

29 November 2017

Richard L Hébert

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

29 November 2017

1 reference

29 November 2017

124

1 reference

29 November 2017

11

1 reference

29 November 2017

685-694

1 reference

Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.

29 November 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Renal effects on a solitary kidney of specific inhibition of cyclooxygenease-2 after 24 h of complete ureteric obstruction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

The effect of cyclooxygenase-2 inhibition on renal hemodynamic function in humans with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Development of late-stage diabetic nephropathy in OVE26 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Nephron number and renal risk in hypertension and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Mouse models of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Renal hyperfiltration is a determinant of endothelial function responses to cyclooxygenase 2 inhibition in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20120543

21 January 2018

Identifiers

DOI

10.1042/CS20120543

1 reference

29 November 2017

1 reference